Skip to main navigation Skip to search Skip to main content

Central nervous system stimulants in recreational and medical use

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Stimulants that act on the central nervous system have been used since antiquity for ritual and other uses. Organic chemistry techniques, especially those developed in Germany in the late 1800s, resulted in the isolation and structural determination of several important stimulants. Synthetic pathways for amphetamine and related stimulants were developed in the first half of the 19th century, and these new drugs were widely marketed. Awareness of abuse potential emerged soon after but was contested. Stimulants have been used to counteract fatigue and promote wakefulness during military operations, as well as to treat sleep disorders, since the 1930s. Methylphenidate was approved to treat children with behavioral problems in 1962, predating the recognition of attention deficit hyperactivity disorder (ADHD). Stimulant abuse became a political concern in the post-war period, initially with the use of pep-pills by long-haul truck drivers and later as drug dealing became common in night clubs, with new laws limiting availability passed in the early 1960s. They have also been used to increase athletic and cognitive performance. Stimulants are still first-line therapies for ADHD and some sleep disorders; however, newer-generation drugs have been developed with better safety profiles and lower abuse potential. Illicit stimulant use continues to be common in many countries.

Original languageEnglish
Article numbere52
Pages (from-to)1 - 11
Number of pages11
JournalCNS Spectrums
Volume30
Issue number1
DOIs
StatePublished - 14 Jul 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Stimulant
  • drug abuse
  • attention-deficit hyperactivity disorder (ADHD)
  • amphetamine
  • catecholamine releasing agents
  • central nervous system
  • Central Nervous System Stimulants/therapeutic use
  • Humans
  • Substance-Related Disorders
  • Attention Deficit Disorder with Hyperactivity/drug therapy

Fingerprint

Dive into the research topics of 'Central nervous system stimulants in recreational and medical use'. Together they form a unique fingerprint.

Cite this